A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection
Stopped Study stopped due to a safety signal of drug-induced liver injury in subjects receiving 2158
Conditions
Interventions
- DRUG: ABI-H2158
- DRUG: Placebo
- DRUG: Entecavir (ETV)
Sponsor
Assembly Biosciences